YOUNG v. COMMUNITY NUTRITION INSTITUTE Case Brief
Complete case briefs with LSD+
Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.
Adaptive Case Views
Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.
Exam-Ready IRAC Format
We deliver the precise structure professors look for in exam answers.
Complex Cases, Clarified
We break down dense legal reasoning into something digestible, helping you grasp core concepts.
Case Brief Summary & Legal Analysis
tl;dr: The Supreme Court deferred to the Food and Drug Administration’s (FDA) interpretation of a food safety statute. The Court found the law’s language grammatically ambiguous and held the FDA reasonably concluded it had discretion, not a mandatory duty, to set formal contamination limits for certain substances.
Legal Significance: This case is a key application of Chevron deference, demonstrating that a court must defer to an agency’s reasonable interpretation of a statute it administers, even when the ambiguity stems from grammatical structure and an alternative reading seems more natural.
Case Facts & Court Holding
Key Facts & Case Background
The Federal Food, Drug, and Cosmetic Act (FDCA) deems food adulterated if it contains an added poisonous substance that is “unsafe.” Section 346 of the Act addresses substances that are required in production or cannot be avoided. For these, the statute provides that “the Secretary shall promulgate regulations limiting the quantity therein or thereon to such extent as he finds necessary for the protection of public health.” The Food and Drug Administration (FDA) has long interpreted this provision as granting it discretion to decide whether to issue such formal regulations, known as “tolerance levels.” For aflatoxin, an unavoidable and carcinogenic contaminant in corn, the FDA opted not to set a formal tolerance level, instead using less formal “action levels” to guide enforcement. The Community Nutrition Institute (CNI) sued, arguing that the word “shall” in § 346 imposes a mandatory, non-discretionary duty on the FDA to promulgate a formal tolerance level for any such substance. The D.C. Circuit Court of Appeals agreed with CNI, finding the statute’s language to be an unambiguous command. The Supreme Court granted certiorari to resolve the dispute over the agency’s statutory authority.
Court Holding & Legal Precedent
Issue: Did the Food and Drug Administration permissibly interpret an ambiguous provision of the Federal Food, Drug, and Cosmetic Act to grant it discretion in deciding whether to promulgate formal tolerance levels for unavoidable food contaminants?
Yes. The Court held that the statutory language was ambiguous and the Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
IRAC Legal Analysis
About IRAC analysis
IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.
Legal Issue
Did the Food and Drug Administration permissibly interpret an ambiguous provision of the Federal Food, Drug, and Cosmetic Act to grant it discretion in deciding whether to promulgate formal tolerance levels for unavoidable food contaminants?
Conclusion
This case reinforces the strength of the *Chevron* doctrine, extending deference to Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
Legal Rule
Under Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U.S. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
Legal Analysis
Applying the two-step framework from *Chevron*, the Court first addressed whether Congress Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
Flash-to-Full Case Opinions
Flash Summary
- The Court applied Chevron deference to the FDA’s interpretation of the